This morning, Johnson & Johnson shared its third-quarter performance.
Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 136,000 employees across the globe working every day to help change the trajectory of health for humanity.
“Johnson & Johnson’s third-quarter results were driven by solid performances across the enterprise,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “As we enter the final quarter of the year, we remain committed to expanding the global reach of our COVID-19 vaccine, continuing differentiated levels of investment in a pipeline of life-enhancing innovation and advancing key commercial platforms to deliver long-term value for all our stakeholders.”
For more details about the company’s 2021 third-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.
Johnson & Johnson’s 2021 3rd-Quarter Earnings
You are now leaving jnj.com
The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.
